Showing results (351-360 of 827) with videos related to
Sort By:
Pageof 83
P & T : a Peer-Reviewed Journal for Formulary Management|November 15, 2014
FDA's Proposed 503B Draft Compounding Guidance Raises Concerns of All Kinds: Is the Bar Being Set Too High, or Too Low?Stephen BarlasP & T : a Peer-Reviewed Journal for Formulary Management|November 15, 2014
The changing roles of p&t committees: a look back at the last decade and a look forward to 2020F Randy Vogenberg, Judith GomesP & T : a Peer-Reviewed Journal for Formulary Management|November 15, 2014
Modest growth seen in epilepsy marketKunj Gohil, Devin EnhofferP & T : a Peer-Reviewed Journal for Formulary Management|December 18, 2014
Another tragic parenteral nutrition compounding errorMatthew GrissingerP & T : a Peer-Reviewed Journal for Formulary Management|December 18, 2014
Interrupting anticoagulation in patients with nonvalvular atrial fibrillationScott W YatesP & T : a Peer-Reviewed Journal for Formulary Management|December 18, 2014
Overview of insulin and non-insulin delivery devices in the treatment of diabetesMichele PisanoP & T : a Peer-Reviewed Journal for Formulary Management|December 18, 2014
European society of medical oncologyWalter AlexanderP & T : a Peer-Reviewed Journal for Formulary Management|November 2, 2017
Safety Requires a State of MindfulnessMatthew GrissingerP & T : a Peer-Reviewed Journal for Formulary Management|November 2, 2017
Drug and Device NewsP & T : a Peer-Reviewed Journal for Formulary Management|November 2, 2017
Evidence for Idarucizumab (Praxbind) in the Reversal Of the Direct Thrombin Inhibitor Dabigatran: Review Following the RE-VERSE AD Full Cohort AnalysisTimothy C Hutcherson, Nicole E Cieri-Hutcherson, Rajvi BhattPageof 83